Unique ID issued by UMIN | UMIN000030592 |
---|---|
Receipt number | R000034933 |
Scientific Title | Prospective survey of efficacy and safety of Deep Brain Stimulation for severe involuntary movement in Tourette syndrome |
Date of disclosure of the study information | 2017/12/27 |
Last modified on | 2019/07/01 16:05:15 |
Prospective survey of efficacy and safety of Deep Brain Stimulation for severe involuntary movement in Tourette syndrome
Prospective survey of Deep Brain Stimulation for severe involuntary movement in Tourette syndrome
Prospective survey of efficacy and safety of Deep Brain Stimulation for severe involuntary movement in Tourette syndrome
Prospective survey of Deep Brain Stimulation for severe involuntary movement in Tourette syndrome
Japan |
Patients with severe involuntary movement in Tourette syndrome
Psychiatry | Neurosurgery |
Others
NO
To study prospectively long- and medium-term effects of DBS in patients with severe involuntary movement in Tourette syndrome which is rare disease
Safety,Efficacy
YGTSS(Yale Global Tic Severity Scale)
Modified Rush Tic Rating Scale, Yale-Brown Obsessive-Compulsive Score, neuropsychological test(WAIS-3,WMS-R,BD1-2,MMPI), Cortical activities measured by NIRS
Observational
12 | years-old | <= |
Not applicable |
Male and Female
1. Patients with Dystonic tic who are to undergo DBS covered by national Health Care Insurance System
2.Patients over 12 years old.
If patients under 12 years old are applicable to the surgery of severe involuntary movement, medical ethical committee will deliberate it.
3.Patients signed an informed consent document.
4.Patient's legal representatives sign an informed consent document if patients are minor.
5.Patients meet DSM-4 for clinical diagnose criteria of Tourette syndrome
6.Patients with severe involuntary movement meet over 35/50 in YGTSS.
7.More than 6 months medication or psychological therapy failed to improve the symptoms or those were intolerant because of side effects.
8.If patients are life-threatening condition by involuntary movements even though YGTSS sore or treatment period or so don't meet inclusion criteria, they are to undergo the surgery after approval by medical ethical committees.
1.High risk patients with physical or mental complications (severe cardiovascular disorder, severe respiratory dysfunction, severe blood diseases, epilepsy, medical history of severe head injuries, severe stroke, severe neurodegenerative diseases, autism, schizophrenic, manic depression, drug addictions, pregnant, breast-feeding, female patients of child-bearing potential
2.Patients ineligible to the study based on investigator's decision.
50
1st name | |
Middle name | |
Last name | Tooru Inoue |
Fukuoka University Hospital
Department of Neurosurgery
7-45-1, Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan
092-801-1011
toinoue@fukuoka-u.ac.jp
1st name | |
Middle name | |
Last name | Takashi Morishita |
Fukuoka University Hospital
Department of Neurosurgery
7-45-1, Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan
092-801-1011
tmorishita@fukuoka-u.ac.jp
Fukuoka University Hospital
Fukuoka University
Self funding
NO
福岡大学病院 Fukuoka University Hospital
2017 | Year | 12 | Month | 27 | Day |
Unpublished
Open public recruiting
2017 | Year | 09 | Month | 15 | Day |
2017 | Year | 12 | Month | 27 | Day |
Prospective survey
2017 | Year | 12 | Month | 27 | Day |
2019 | Year | 07 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034933